Skip Page Header

Home > Canadian substance use costs and harms in the provinces and territories (2007–2014).

Canadian Substance Use Costs and Harms Scientific Working Group. (2018) Canadian substance use costs and harms in the provinces and territories (2007–2014). Ontario: Canadian Centre on Substance Use and Addiction.

[img]
Preview
PDF (Canadian substance use costs and harms in the provinces and territories (2007–2014).)
4MB

Canadian Substance Use Costs and Harms (2007–2014) updates and expands upon a landmark study from 2006, The Cost of Substance Abuse in Canada 2002. The update took advantage of more complete data and improved analytic techniques to provide cost estimates across a broad range of substances, including alcohol, tobacco, cannabis, opioids, other central nervous system (CNS) depressants (including benzodiazepines, barbiturates, etc.), cocaine, other CNS stimulants (including amphetamine, methamphetamine and ecstasy) and other substances (including hallucinogens and inhalants). In addition to detailing national estimates by substance, the report also presented data by cost type (i.e., healthcare, lost productivity, criminal justice and other direct costs), province and territory, and year, and provided a detailed description of the methods used.

Item Type
Report
Publication Type
International, Report
Drug Type
All substances
Intervention Type
General / Comprehensive
Date
December 2018
Pages
42 p.
Publisher
Canadian Centre on Substance Use and Addiction
Corporate Creators
Canadian Substance Use Costs and Harms Scientific Working Group
Place of Publication
Ontario
EndNote

Repository Staff Only: item control page